These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26431582)

  • 1. Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer.
    Czarnowicki T; Malajian D; Khattri S; Correa da Rosa J; Dutt R; Finney R; Dhingra N; Xiangyu P; Xu H; Estrada YD; Zheng X; Gilleaudeau P; Sullivan-Whalen M; Suaréz-Fariñas M; Shemer A; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Apr; 137(4):1091-1102.e7. PubMed ID: 26431582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.
    Clausen ML; Jungersted JM; Andersen PS; Slotved HC; Krogfelt KA; Agner T
    Br J Dermatol; 2013 Sep; 169(3):587-93. PubMed ID: 23647067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrier repair therapy in atopic dermatitis: an overview.
    Hon KL; Leung AK; Barankin B
    Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
    Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
    J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial.
    Czarnowicki T; Dohlman AB; Malik K; Antonini D; Bissonnette R; Chan TC; Zhou L; Wen HC; Estrada Y; Xu H; Bryson C; Shen J; Lala D; Ma'ayan A; McGeehan G; Gregg R; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):631-640.e11. PubMed ID: 29567358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis.
    Asano S; Ichikawa Y; Kumagai T; Kawashima M; Imokawa G
    Br J Dermatol; 2008 Jul; 159(1):97-104. PubMed ID: 18476959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
    Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moisturizing effects of topical nicotinamide on atopic dry skin.
    Soma Y; Kashima M; Imaizumi A; Takahama H; Kawakami T; Mizoguchi M
    Int J Dermatol; 2005 Mar; 44(3):197-202. PubMed ID: 15807725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.
    Esaki H; Ewald DA; Ungar B; Rozenblit M; Zheng X; Xu H; Estrada YD; Peng X; Mitsui H; Litman T; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Jan; 135(1):153-63. PubMed ID: 25567045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma.
    Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Kawaguchi M; Takahashi N; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2014 Aug; 20(16):4339-48. PubMed ID: 24919568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence.
    Quadri M; Lotti R; Bonzano L; Ciardo S; Guanti MB; Pellacani G; Pincelli C; Marconi A
    Skin Pharmacol Physiol; 2021; 34(1):8-18. PubMed ID: 33601378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis.
    Batista DI; Perez L; Orfali RL; Zaniboni MC; Samorano LP; Pereira NV; Sotto MN; Ishizaki AS; Oliveira LM; Sato MN; Aoki V
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1091-5. PubMed ID: 25271795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of conventional therapy in atopic dermatitis.
    Wollenberg A; Schnopp C
    Immunol Allergy Clin North Am; 2010 Aug; 30(3):351-68. PubMed ID: 20670818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Jul; 12(7):s85-91. PubMed ID: 23884506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin capacitance in normal and atopic infants, and effects of moisturizers on atopic skin.
    Matsumoto T; Yuasa H; Kai R; Ueda H; Ogura S; Honda Y
    J Dermatol; 2007 Jul; 34(7):447-50. PubMed ID: 17584321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults.
    Simpson E; Dutronc Y
    J Drugs Dermatol; 2011 Jul; 10(7):744-9. PubMed ID: 21720656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis.
    Jensen JM; Fölster-Holst R; Baranowsky A; Schunck M; Winoto-Morbach S; Neumann C; Schütze S; Proksch E
    J Invest Dermatol; 2004 Jun; 122(6):1423-31. PubMed ID: 15175033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis.
    Na JI; Hwang JS; Park HJ; Kim DH; Park WS; Youn SW; Huh CH; Park KC
    J Dermatolog Treat; 2010 Jan; 21(1):23-7. PubMed ID: 19626524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.